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1. Introduction 
Presence of tumor cells in blood of patients with metastatic carcinomas has been associated 
with poor progression free and overall survival (Cohen et al., 2008; Cristofanilli et al., 2004; 
de Bono et al., 2008). Assessment of treatment targets on circulating tumor cells (CTC) 
before initiation of therapy may provide a means to guide therapy (Attard et al., 2009; de 
Bono et al., 2007; Hayes et al., 2002; Meng et al., 2006; Meng et al., 2004; Smirnov et al., 2005; 
Swennenhuis et al., 2009). Characterization of CTC can be performed by Fluorescence In Situ 
Hybridization (FISH) which has been used to prove that CTC are indeed malignant (Fehm et 
al., 2002; Swennenhuis, et al., 2009), and that gene amplifications, deletions and 
translocations related to certain therapies can be detected (Attard, et al., 2009; Meng, et al., 
2006; Meng, et al., 2004).  
CTC are extremely rare in most patients: 1-10/7.5 ml of blood (Allard et al., 2004), among 
about 50 million leukocytes and 50 billion erythrocytes within that volume. For accurate 
characterization of the CTC it is thus of utmost importance that no cell loss is incurred and 
the error in the interpretation of the results is kept to a minimum. The CellSearch® system is 
the only clinically validated system for counting CTC (Allard, et al., 2004; Kagan et al., 2002). 
It is based firstly on immunomagnetic enrichment of the blood sample using antibodies 
directed against the epithelial cell adhesion molecule (EpCAM). A second step consists of 
labeling the enriched sample with fluorescent dyes for the nucleus and cytokeratins 8, 18, 
and 19; CD45 labeling to recognize leukocytes. In a third step, fluorescence images are 
recorded of the enriched and labeled sample. CTC candidates are presented to a trained 
reviewer who distinguishes CTC from debris and leukocytes. Limitation of the CellSearch 
system is that only CTC expressing both EpCAM and CK8, 18 and or 19 will be detected.  
Recently, we have developed a semi-automated method for FISH analysis of CTC after they 
have been identified by the CellSearch™ system. Interpretation of FISH results is however 
encumbered by apoptosis of CTC, which is observed frequently. In addition, counting of 
FISH dots can be tiring and subjective, and thus likely results in differences in intra-
reviewer and inter-reviewer interpretation. Automation of counting of these FISH signals -
termed FISH dots hereafter-  could resolve these challenges. Other work has been done in 
the field of automated counting of FISH dots: on cell lines (Netten et al., 1997), blood from 
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healthy individuals (de Solorzano et al., 1998), cells from amniotic fluid (Lerner et al., 2001), 
and on tissue (Raimondo et al., 2005). An excellent overview of methods is available (Restif, 
2006). However, to our knowledge, automated dot counting has never been applied in 
samples containing containing CTC. The nuclei and dots of these cells are extremely 
heterogeneous in shape and intensity, and therefore difficult to score, even by reviewers. 
Therefore, we investigated the error in counting FISH dots, and evaluated different methods 
to count the FISH dots by a computer algorithm. 
2. Method 
2.1 Patient samples 
A prospective multicenter clinical trial that evaluated the utility of counting CTC for 
predicting response to therapy, progression-free survival, and overall survival in metastatic 
castration-resistant prostate cancer patients was conducted (de Bono, et al., 2008). A total of 
65 clinical centers throughout the United States and Europe participated in this study after 
formal institutional review board approval. All patients were required to provide written 
informed consent. Blood was collected before starting a new treatment and at monthly 
intervals prior to the next cycle of therapy.  
2.2 Sample preparation for CTC enumeration 
Blood samples were drawn into 10 mL evacuated blood draw tubes, maintained at room 
temperature, and processed within 96 hours of collection. The CellSearch System (Veridex 
LLC, Raritan, NJ) consists of the CellTracks Autoprep®, CellTracks Magnest®, CellSearch 
Epithelial Cell Kit and the CellTracks Analyzer II®. The CellSearchTM Epithelial Cell Kit 
contains: -ferrofluids labeled with the epithelial cell adhesion molecule (EpCAM); -staining 
reagents 4’,2-diamidino-2-phenylindole, (DAPI), CD45-Allophycocyan (CD45-APC), 
cytokeratin 8, 18 Phycoerythrin, cytokeratin 19 Phycoerythrin (CK-PE); buffers to enhance 
cell capture (Rao et al., 2005), cell permeabilization and cell fixation. The CellTracks 
Autoprep immuno-magnetically enriches cells expressing EpCAM from 7.5 ml of blood, 
fluorescently labels the enriched cells with DAPI, CD45-APC and CK-PE, and re-suspends 
the cells in the cartridge placed in the CellTracks Magnest. The design of the magnets guides 
the magnetically labeled cells to the analysis surface (Tibbe et al., 2002).  
2.3 Data acquisition for CTC enumeration 
The CellTracks Magnest containing the cartridge is placed on the CellTracks Analyzer II a 
semi-automated fluorescence-based microscopy system that acquires images using a 
10X/0.45NA objective with filters for DAPI, FITC, PE, and APC to cover the complete 
surface area of the cartridge. The CellSearch software identifies objects staining with DAPI 
and PE in the same location and generates images for the DAPI, FITC, PE, and APC filters. 
A reviewer selects the CTC defined as nucleated DAPI+ cells larger than 4 m, lacking 
CD45-APC and expressing CK-PE from the gallery of objects, which are tabulated by the 
computer.  Figure 1 shows an overview of the image acquisition and identification of CTC. 
After a scan, the cartridges were stored at room temperature until the reviewer was finished 
reviewing the images. Accuracy, precision, linearity, and reproducibility of the CellSearch 
system have been described elsewhere (Allard, et al., 2004). 
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Fig. 1. Image acquisition in CellSearch. 1) Ferrofluid and staining reagents are added to the 
blood sample. 2) After immuno-magnetic enrichment and fluorescent labeling, the sample is 
inserted in a cartridge. 3) The cartridge is  inserted into a Magnest to distribute the labeled 
cells over the analysis surface. 4) The cartridge is scanned at 10X in the CellTracks Analyzer. 
5) CK+ DAPI+ objects are presented to the reviewer for CTC selection. 6) Coordinates of 
selected CTC are collected. 7) The coordinates and images from the scan are saved on a CD 
or DVD.  
2.4 Samples used for FISH counting algorithm development 
For algorithm development, images from cells of a patient in which no CTC were detected 
were used. Leukocytes which were non-specifically carried over during the CTC enrichment 
procedure were used as targets for this purpose, as in these cells almost no chromosomal 
aberrations are present and each cell should therefore contain two copies of each 
chromosome and gene region. The sample was labeled with a centromere specific FISH 
probe for chromosome 17 and a probe identifying the HER2 gene region. The centromere 
probe is larger than the HER2 probe, thus a difference in automated count could be 
expected. For the validation of the algorithm, CTC from 47 patients with hormone refractory 
metastatic prostate cancer labeled with probes identifying the centromeres of chromosome 
1, 7, 8 and 17 were used (Swennenhuis, et al., 2009).  
2.5 Sample preparation for FISH probes on CTC 
Cartridges containing CTC were used for the FISH procedure. To preserve the location of 
the CTC for future interrogation the buffer inside the cartridge was carefully aspirated 
aspirated  to avoid cell cell movement and replaced with methanol acetic acid. After fixation 
the cartridges are dried using a forced forced air flow flow and processed for FISH or stored 
at -20 °C for later use. FISH probes specific for the centromeric regions of chromosome 1, 7, 
8, and 17 labeled with PlatinumBright-647, -550, -505, and -415, respectively, were used in 
this study (Kreatech, Amsterdam, The Netherlands). The probe mixture consisted of 50 µL 
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of hybridization buffer (50% Formamide / 1 x SSC / 10% Dextran Sulfate) containing FISH 
probes against 1, 7, 8, and 17 at 2 ng/µL each. The cartridges were placed on a 80°C hotplate 
for 2 min, with the glass facing towards the hotplate, and hybridized at 42°C for 16 h. After 
hybridization the cartridge was washed with PBS containing DAPI (use abbreviation instead 
of whole word) as a nuclear counter stain. 
2.6 Data acquisition for FISH probe detection in CTC  
After hybridizing the FISH probes, the samples were scanned on a modified CellTracks 
Analyzer II. This analyzer is equipped with a 40X/0.63NA objective, to improve the 
resolution and light collection of the fluorescent FISH dots, and filter cubes to detect DAPI, 
PlatinumBright-647, -550, -505, and 415. The locations and images of the CTC identified in 
the initial 10X scan -described in 2.3- were loaded from a CD. A software program was 
written to move to the locations of interest and record Z-stacks to capture signals at a range 
of depths of the objects of interest (Swennenhuis, et al., 2009). The DAPI signals are used to 
correlate the 40X with the 10X scan, thereby verifying if the CTC location is correct. This was 
necessary, as the cells could shift up to ~200 µm due to the FISH protocol. The image 
acquisition procedure for the FISH probe detection is shown in figure 2. 
 
Fig. 2. Procedure for FISH probe imaging. 1) The cartridge is re-opened to carefully aspirate 
buffer and fixate the cells. 2) FISH reagents are added and the sample is hybridized for 16h. 
3) Coordinates and images from previously assigned CTC are loaded from a CD. 4) The 
modified CellTracks records DAPI images at 40X at the designated coordinates and 
surroundings. 5) Cross correlation is performed between the DAPI images from the 40X and 
10X scan to verify the correct location of the CTC. 6) After the right location is found, the 
FISH z-stacks are recorded.  
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2.7 Algorithm for counting FISH signals in leukocytes and CTC 
Maximum intensity profiles were created of all the Z-stacks to speed up the counting 
process for human reviewing. The algorithm to identify the nucleus and count the FISH 
probes within this nucleus consists of five general steps:  
1. enhancement and segmentation of the outline of the nucleus;  
2. enhancement and segmentation of potential FISH objects;  
3. exclusion of objects that are too noisy; 
4. measurement of intensity and morphological features of the potential objects;  
5. exclusion of objects that do not meet inclusion criteria.  
Nuclei were located in the DAPI image, which was enhanced using a zero-crossing filter in 
combination with a gradient magnitude filter (Verbeek & Vanvliet, 1994). Edges were 
enhanced using a morphological gradient magnitude filter. The image of this filter was 
multiplied by an image filtered by a laplace-plus-dgg filter. This filter created a combination 
of second order derivatives in x and y, and combined it with an image of the second 
derivative in the direction of the maximum gradient. The combined image of the two filters 
is thresholded using a fixed threshold. On the outline of objects larger than 2000 pixels a 
distance transform was applied: every outline pixel value is replaced by its closest distance 
to the edge of the outline. This procedure was then followed by a watershed transform, to 
verify if the outline consisted of multiple maxima and were thus two or more closely spaced 
objects.  Figure 3 shows how a distance transform improves the watershed transform in case 
of saturated DAPI signals. The nucleus that was at least 250 pixels in size and located closest 
to the middle of the image was selected as the final outline: only objects inside this outline 
are considered for FISH dot counting. 
 
Fig. 3. Example of a distance transform aiding the watershed transform. Panel A shows the 
original DAPI image containing three nuclei which is thresholded to give the outline at 
panel B. This outline is difficult to watershed due to saturation in the original image. The 
distance transform shown in panel C creates a new input for the watershed transform, 
which successfully separates the nuclei as is shown in panel D. 
In a next step, dot-like structures were enhanced. Usually this is performed by employing a 
tophat filter (Netten, et al., 1997). We used a method termed multiscale product (Vermolen 
et al., 2008) because it appeared better suited to deal with the heterogeneity of the shapes of 
the FISH probes. This filter increases the intensity of objects in a range of radii, using a 
multiplication of Gaussian kernels with different σ (ranging from 1.5 to 3.0 pixels): 
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Using a range of Gaussian kernel sizes improves robustness to variations in size of the 
objects of interest, compared to using a single kernel size as is done in the tophat transform 
method. After applying the multiscale product, objects were thresholded using the triangle 
threshold (Zack et al., 1977) which was multiplied by a factor of 0.1 to include all relevant 
dot-like structures, bright or dim. This thresholding method uses the intensity histogram of 
the image and is especially suited for images with few object pixels. After thresholding, a 
final verification was performed to exclude objects that are too noisy. The dome finding 
method of Restif was applied to the coordinates of the maximum of each object (Restif, 
2006). This method checks nearest downhill neighbors in three level sets -up to three pixels 
around the maximum- and excludes objects that have more than one extra local maximum 
in this region. Figure 4 shows the method by which nearest downhill neighbors are checked.  
 
 
Fig. 4. Scheme for checking downhill neighbors. By checking objects in this way only dome 
shape objects are included. (adapted from (Restif, 2006)) 
Restif et al. determined that if one extra local maximum is allowed, at least 75% of the 
downhill neighbors should have a lower intensity. We allow one extra local maximum to 
include very closely spaced FISH dots. In this way, noisy objects are excluded, whether or 
not this noise is originating from a high or low intensity background. Finally, measurements 
were performed on these objects: size, maximum intensity, mean intensity, total intensity, 
relative intensity, roundness, and perimeter were saved for every object. Relative intensity 
was defined as the total intensity of the object related to the total intensity of the brightest 
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object within the same nucleus. Using these measurements, different exclusion criteria were 
tested. Combinations of measurements were tested on the leukocyte training set to exclude 
debris and keep the true FISH dots.  Figure 5 gives a schematic overview of the procedure. 
 
 
 
Fig. 5. Schematic representation of the counting process. DAPI images are loaded and their 
outline is determined. Within this outline, a multiscale product is applied. Objects within 
outline 1 are thresholded and checked for dome-like structures. Finally, the objects are 
counted and measured. 
2.8 Expert reviewing of samples 
Next to the algorithm, five expert reviewers counted FISH probe signals in the leukocytes, 
using a macro written in the program ImageJ (Collins, 2007). They reviewed the set two 
times: the first time they were asked to review all images, the second time they could skip 
images that were unclear in their view. In this way it could be measured how sure reviewers 
were. All CTC samples were also reviewed by the five expert reviewers.  
3. Results 
492 leukocytes and 500 CTC were imaged by the modified CellTracks Analyzer II. Figure 6 
shows an example of a FISH Z-stack from a leukocyte in top and slice view, from which a 
maximum profile was created. The profiles were processed by the algorithm, requiring ~2 
minutes for each sample and counted by human reviewers, requiring ~2 hours for each 
sample. Figure 7 shows the different steps of the algorithm: segmentation of the nucleus, 
enhancement of dot-like structures and the final outline of nucleus and the dots.  
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Fig. 6. Example of a recorded Z-stack of FISH probes in a leukocyte in top-view, panel A,  
and in slice-view, panel B. Distance between the slices is 1 µm 
 
 
Fig. 7. Example of the image processing steps on a recorded DAPI and FISH image. 1) 
original DAPI image; 2) edge enhanced DAPI image; 3) outline after thresholding and 
watershed; 4) final DAPI outline; 5) original FISH image; 6) FISH image after multiscale 
product; 7) outline FISH image; 8) final outlines of DAPI and FISH. 
3.1 Counting of the leukocyte training sample 
After comparison of the manual and automated counts in the training sample, it became 
apparent that only the measurements “size” and “relative intensity” had a positive impact 
on the counting efficiency of the algorithm. After objects were measured and counted in the 
HER2 channel the objects, with a relative intensity lower than 30% of the brightest dot, 
within that nucleus were excluded. For the centromere 17 channel this threshold was 
optimal at 25%. Objects smaller than 5 pixels were also excluded. Automatic counting of 
chromosomes in leukocytes resulted in an accuracy of 97.8% of the HER2 dots and 97.5% of 
the centromere 17 dots. Accurate here means “equal to the manual count of the subset of 
images were all reviewers agreed upon” (n=409 for HER2 and n=347 for centromere 17). The 
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mean inter-reviewer agreement was 92.6%±2.3% and 91.7%±1.7% and the mean intra-
reviewer agreement was 96.5%±2.7% and 97.0%±1.8% for the HER2 and centromere 17 
probes, respectively. Table 1 gives an overview of the counting efficiencies after review of 
HER2 and centromere 17 of the whole data set and the data set containing only the images 
with objects that could be easily identified by the reviewer, compared with the count 
generated by the algorithm. In figure 8 the distribution of the count of the PC and five 
reviewers are shown. The count of the reviewers is represented by the mean and the 
standard deviation for each chromosome count.  
 
HER2 Rev 1 Rev 2 Rev 3 Rev 4 Rev 5 PC 
Rev 1 96.2%±1.7% 91.3%±2.5% 93.9%±2.1% 93.5%±2.2% 95.5%±1.9% 90.3%±2.6% 
Rev 2 91.3%±2.5% 92.5%±2.3% 89.9%±2.7% 89.3%±2.7% 90.9%±2.6% 85.0%±3.2% 
Rev 3 93.9%±2.2% 91.0%±2.6% 95.7%±1.8% 92.7%±2.3% 96.0%±1.8% 90.5%±2.6% 
Rev 4 98.7%±1.2% 97.7%±1.6% 97.9%±1.5% 99.2%±1.0% 92.9%±2.3% 87.6%±2.9% 
Rev 5 97.3%±1.5% 93.0%±2.3% 96.2%±1.8% 99.2%±1.0% 98.9%±1.0% 92.1%±2.4% 
PC 90.5%±2.6% 87.4%±2.9% 89.8%±2.7% 96.9%±1.8% 92.6%±2.4% 100.0%-0.4% 
Cent17       
Rev 1 96.4%±1.7% 92.9%±2.3% 92.7%±2.3% 93.7%±2.2% 90.5%±2.6% 87.6%±2.9% 
Rev 2 92.3%±2.4% 94.9%±2.0% 93.9%±2.1% 90.7%±2.6% 92.3%±2.4% 88.1%±2.9% 
Rev 3 95.0%±2.0% 94.5%±2.1% 96.0%±1.8% 90.3%±2.6% 91.7%±2.5% 85.4%±3.1% 
Rev 4 96.1%±1.9% 98.3%±1.3% 97.0%±1.7% 99.0%±1.0% 88.5%±2.8% 89.1%±2.8% 
Rev 5 96.0%±1.9% 96.0%±1.9% 98.1%±1.4% 96.4%±1.9% 98.6%±1.2% 88.5%±2.8% 
PC 87.4%±2.9% 91.5%±2.5% 88.4%±2.9% 95.4%±2.1% 91.7%±2.7% 100.0%-0.4% 
Table 1. Agreement between expert reviewers and the PC algorithm when reviewing 
leukocytes. In the upper right part of the table (white), the agreement of the first review is 
shown in which the reviewer had to review the full dataset (n=492). Second, in the lower left 
part of the table (dark grey) the agreement of the second review is shown, in which the 
reviewers only reviewed the cells they were certain of (the “obvious” dataset).  Last, the 
intra-reviewer variation is given on the diagonal of the table (light grey).  
 
Fig. 8. Number of leukocytes for the HER2 gene probe (panel A) and the centromere of 
chromosome 17 probe (panel B) as counted by the PC and the five reviewers (n=492).  
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Fig. 9. Example of FISH images. Panel A shows cases were all reviewers and the PC agreed. 
Panel B shows examples were all the human reviewers agreed, but the PC disagreed on the 
number of FISH dots. Panel C shows examples with the largest discrepancy among 
reviewers. 
3.2 Counting of a sample containing CTC  
After processing a sample containing CTC it became clear that the threshold for relative 
intensity was strongly related to the quality of the FISH probe used, and thus probe 
dependent. Slight adjustment of the relative intensity criteria to a range from 14%-20% was 
necessary to ensure reasonable counting by the algorithm. This value was correlated with 
the average of the maximum intensity of all the objects in a channel: if this average was 
high, then the relative intensity should be set lower. Figure 9 shows three categories of 
examples from the data set: panel A shows examples were all the reviewers and the PC 
agreed; panel B shows examples were all reviewers agreed, but the PC did not; finally, panel 
C shows examples where there was a large discrepancy between all reviewers and the PC.  
Agreement of the PC with the subset of cells on which all reviewers agreed was 76.1% 
(n=238), 83.9% (n=280), 86.6% (n=209), and 85.3% (n=251) for probes from centromere 1, 7, 8, 
and 17 respectively. Mean inter-reviewer agreement was 70.9%, 75.3%, 66.8%, and 72.3% for 
these four channels. Figure 10 show the agreement between all reviewers in detail and the 
histogram of the count.  
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Fig. 10. Number of CTC containing 0-6 or >6 dots for the centromere of chromosomes 1,7,8, 
and 17 probe (panel A-D) as counted by the PC and the five reviewers (n=500). The reviewer 
count is given as the mean of the frequency of each number and its standard deviation. 
4. Conclusion 
4.1 Automated counting is necessary and feasible 
We have shown that reliable automated counting of FISH probes on 
EpCAM+DAPI+CK+CD45- cells is both necessary and feasible. Comparing expert reviews 
revealed that intra-reviewer variation -the same expert reviewing a data set twice- could be 
as high as 3.5% of the cells. Inter-reviewer variation was higher: 7.5%; these numbers were 
both acquired for the “easy” leukocyte samples with low copy numbers. Variation between 
reviewers while reviewing CTC samples could be as high as 33.2% (centromere 
chromosome 8), showing that the number of signals in a nucleus is of great influence on 
counting accuracy, as is the knowledge of the reviewer that he or she is dealing with CTC or 
leukocytes. Furthermore, reviewing 500 FISH nuclei in four channels takes several hours, 
while the computer only needs a few minutes.  
From the results it becomes clear that review of chromosome 1 and 8 was the most difficult, for 
both PC and reviewer. These probes had on average a factor two lower intensities than the 
probes from chromosomes 7 and 17. Thus, the inter-reviewer agreement was lower as well as 
the agreement with the PC. The dome finding part of the algorithm revealed the same: it 
removed objects that were too noisy in 17% and 13% of the nuclei in the channel from 
chromosome 1 and 8 respectively, and only in 8% of the nuclei from channels of chromosome 
7 and 17. Signal to noise ratios were clearly lower in channels were the agreement was lower.  
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4.2 Sources of error for human and PC 
Agreement between PC and reviewer was good when control samples were reviewed, and 
reasonable when CTC were reviewed. The difference between the two data sets could be 
attributed to a few main sources of error:  
1. Nuclei were well separated in the leukocyte sample, the CTC samples contained more 
clusters. While these clusters are usually easily resolved by eye, the algorithm had more 
difficulty in this task. Figure 9, panel B shows an example in row 1: two closely spaced 
nuclei with almost saturated intensity. In this case the signals of the nuclei are close to 
saturation and although a distance transform and watershed transform was applied, 
they were still segmented as one. The PC thus over-counted in this example. 
2. Because the DAPI signal from the nuclei can vary greatly between samples, some 
signals fall just outside the segmented outline of the nucleus as determined by the 
algorithm. This is the case when the signal from the nucleus is relatively dim, as is 
shown in figure 9, panel B, row 4, where the reviewers counted two probes and the PC 
counted only one. This challenge could be resolved by dilating the outline nuclei more 
than is done now. However, closely spaced nuclei will be resolved worse in this case. 
The heterogeneity of the shape and size of the nucleus is largely due to presence of 
ferrofluid in combination with the fixation step in the FISH procedure. The ferrofluid 
particles were added to keep the cells tightly located to the imaging surface.  However, 
due to the influence of these magnetic particles and the tendency of some cells to adhere 
to surfaces, the DNA spreads over the surface. Ferrofluid particles that line up under 
influence of the magnetic field force these cells to spread even further. Thus in the DAPI 
images even small islands of DNA were visible, that clearly were part of a bigger 
nucleus, making it more difficult for the algorithm to measure a perfect outline of the 
nucleus and include all the DNA in the dot counting. Figure 11 shows an example of 
this effect.  
 
 
Fig. 11. Example of a nucleus spread due to fixation of the cell. Note the vertical lines that 
were created by ferrofluid aggregates that follow the local magnetic field. This type of 
nucleus is especially difficult to segment correctly. 
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3. The CTC sample had a larger variety in signal quality. Although the segmentation 
algorithm is dynamic on the histogram, it is still difficult for the PC to distinguish 
between what a reviewer calls a “true signal” and debris. For example, when a reviewer 
sees two signals -a bright and a relatively dim one-, he or she will usually count two. 
However, when five bright signals and one dim signal are seen, the dim object is more 
often neglected. Figure 9 panel B rows 2 and 3 show examples of difference in counting 
because of relative intensity. In row 2, the reviewers counted five and the pc four, while 
in row three, the reviewers counted two and the PC three probes. The PC counts 100% 
reproducible, but does not take into account these human considerations. For this 
analysis, it is thus very difficult to get an absolute “golden truth”.  
4. It still is hard for the PC to distinguish between a split probe (one chromosome that had 
two signals) and two closely spaced chromosomes. It is however not known how often 
a reviewer misclassifies such an object. A reviewer can structurally ignore or assign the 
split spots. The PC cannot and counts these items according to the algorithm. The 
number of cells that have these split spots may vary between samples and also within 
samples (e.g. between lymphocyte and CTC). The PC might not be able to distinguish 
between these, but if this factor appears to be of influence to the result, the PC could use 
the measurements of the probes -i.e. relative intensity coupled to size of closely spaced 
probes- to estimate the probability of these splits in the cells. Leukocytes could be used 
as an internal control for measuring the frequency of these splits and for estimating a 
relevant “size/relative intensity” threshold. 
The above error sources may seem a big challenge, but are not of importance for the clinical 
relevant observations, which is the presence or absence of aneuploidy to ascertain the 
cancerous origin of the cells and the presence of amplification or deletions of specific genes 
that may be used to guide certain therapies. CTC are very heterogeneous: within one patient 
a wide variety of chromosomal aberrations could be spotted. So whether or not a certain cell 
has five or six copies is of lesser importance than the fact that this number is greater than 
two. When comparing counts that are greater than two or not, the reviewer and PC concur 
in 87%, 93%, 94%, and 94% of the cells for centromere 1, 7, 8, and 17 respectively for the data 
set in which all reviewers agree. This demonstrates that in about 90% of the cases, the PC 
and reviewer will draw the same conclusion about the ploidy status of the cells identified as 
tumor cells.   
Figure 9 panel C shows examples in which the reviewers greatly disagreed. Two examples 
of varying signal intensities (rows 1 and 2) and two examples of difficulty of locating the 
true outline of the nucleus (row 3 en 4) are given. It could be argued that the example of row 
1 isn’t suitable for reviewing at all because the background staining is too high. For 
reviewers, there is no real quantitative criterion whether or not to reject a certain object 
based on its intensity distribution. However, the PC has such a criterion: it can easily check 
if a maximum of an object is surrounded by more than two other local maxima. If this is the 
case, then an object should be excluded. We perform this verification by means of the dome 
finding function. In this way, the PC performs more reliable than the human reviewers. 
4.3 Future research 
In the future, the algorithm may be optimized further by using clinical data. When coupling 
for instance response to a therapy of a patient to the aberration of the genes in the CTC the 
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treatment is targeting, a better golden truth may be found. Furthermore, quality of FISH 
could still be improved. Split probes are still a big challenge for the PC, but also for 
establishing a good count by reviewers. Consequently a quality score could be set by the 
algorithm by measuring intensity variations, for instance in carried-over leukocytes. This 
score could be used as an internal control in each patient sample to adjust exclusion criteria 
and to reject cells that are not suitable for interpretation. Finally, removal of ferrofluid could 
greatly improve the segmentation of the nucleus. Aggregation of ferrofluid particles 
disturbs the natural shape of the nucleus and blocks a fraction of the fluorescence light. 
Implementation of physical filters to enrich CTC by size would not require any ferrofluid 
and could be an improvement in the next generation tumor cell capturing devices.  
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